• OPEN AN ACCOUNT
Indian Indices
Sensex
71,560.61 -1,078.09
( -1.48%)
Global Indices
Nasdaq
51,194.40 -347.88
(-0.67%)
Dow Jones
7,822.15 -17.78
(-0.23%)
Hang Seng
69,343.08 -692.63
(-0.99%)
Nikkei 225
10,456.95 -84.74
(-0.80%)
Forex
USD-INR
96.37 0.10
(0.10%)
EUR-INR
108.33 0.45
(0.42%)
GBP-INR
127.68 0.44
(0.34%)
JPY-INR
0.61 0.00
(0.01%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.604918
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
40.67
78.16
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

D & H India consolidated net profit rises 14.85% in the March 2026 quarter
May 30,2026
Net profit of D & H India rose 14.85% to Rs 2.32 crore in the quarter ended March 2026 as against Rs 2.02 crore during the previous quarter ended March 2025. Sales rose 22.13% to Rs 72.24 crore in the quarter ended March 2026 as against Rs 59.15 crore during the previous quarter ended March 2025.

For the full year,net profit rose 62.72% to Rs 8.38 crore in the year ended March 2026 as against Rs 5.15 crore during the previous year ended March 2025. Sales rose 20.84% to Rs 252.71 crore in the year ended March 2026 as against Rs 209.13 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales72.2459.15 22 252.71209.13 21
OPM %6.607.56 -7.256.94 -
PBDT4.923.65 35 14.8510.51 41
PBT3.852.92 32 11.237.56 49
NP2.322.02 15 8.385.15 63